Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03696212
Brief Title: Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma

First Submitted : October 3, 2018
First Submitted that Met QC Criteria : October 3, 2018
First Posted : October 4, 2018

Last Update Submitted that Met QC Criteria : February 19, 2021
Last Update Posted : February 21, 2021